Aastrom Biosciences Inc. (ASTM) Stock Quote

Detailed Quote for Aastrom Biosciences Inc. (ASTM) 
$ 1.49   -0.0001 (-0.01%) Volume: 14.67 k 10:24 AM EDT Sep 2, 2010
Today 5d 1m 3m 1y more
Last Price
1.49
Change $
0.0001
Change %
0.01%
Tick
  
Bid
1.49
Bid Size
1500
Ask
1.50
Ask Size
100
Open
1.51
High
1.51
Low
1.48
Prev Close
1.4901
Last Trade
10:24
Volume
14.67 k
52 Wk Hi
4.148
52 Wk Low
1.32
Market Cap
42.1 m
Ex-Div Date
N/A
Div Rate
N/A
Yield
N/A
Shares
28,255,889
EPS (TTM)
-0.72
PE Ratio
N/A
Exchange
NSC
News and Media for Aastrom Biosciences Inc.  (ASTM) 
Sector News | Topic News
News for ASTM
Tue, Aug 17, 2010
8:30 AM Aastrom Biosciences Reports Fourth Quarter and Fiscal Year 2010 Operating Results - Globe Newswire
Thu, Aug 05, 2010
1:01 PM Webcast Alert: Aastrom to Host Fourth Quarter Investor Conference Call - Globe Newswire
Mon, Aug 02, 2010
11:40 AM Aastrom Biosciences, Inc. Announces Date of 2010 Annual Meeting of Shareholders - Globe Newswire
Wed, Jul 14, 2010
2:45 PM CRWE Wallstreet Announces Stock Watch on SSHO, ENOC, ASTM, NTWK - World Stock Wire
2:40 PM CRWE Wallstreet Announces Stock Watch on SSHO, ENOC, ASTM, NTWK - World Stock Wire
8:31 AM Aastrom Initiates IMPACT-DCM Extension Study for Control Patients - Globe Newswire
Tue, Jul 06, 2010
9:31 AM Aastrom to Pursue Phase 3 Clinical Program in CLI - Globe Newswire
Fri, Jun 11, 2010
8:42 AM Interim Results From Aastrom Critical Limb Ischemia Study Presented Today at Society for Vascular Surgery Annual Meeting - Globe Newswire
Tue, Jun 08, 2010
9:09 AM Scott C. Durbin Joins Aastrom as Chief Financial Officer - Globe Newswire
Fri, Jun 04, 2010
8:33 AM Webcast Alert: Aastrom to Host Investor Conference Call and Webcast on June 11, 2010 Following Presentation at Society for Vascular Surgery Meeting - Globe Newswire
Thu, May 27, 2010
8:32 AM Aastrom to Participate in First Annual Stem Cell Investor & Executive Networking Conference Event - Globe Newswire
Thu, May 20, 2010
8:31 AM Aastrom Announces Senior Management Appointments - Globe Newswire
Mon, May 17, 2010
8:32 AM First Patient Treated in Aastrom's U.S. Phase 2 Catheter Clinical Trial in Dilated Cardiomyopathy - Globe Newswire
8:32 AM First Patient Treated in Aastrom's U.S. Phase 2 Catheter Clinical Trial in Dilated Cardiomyopathy - Globe Newswire
Mon, May 10, 2010
8:36 AM Aastrom Reports Third Quarter Fiscal Year 2010 Financial Results - Globe Newswire
Mon, May 03, 2010
3:21 PM Webcast Alert: Aastrom to Host Investor Conference Call on Critical Limb Ischemia and Related Clinical Development Progress - PR Newswire
8:31 AM Interim Results From Aastrom's Vascular Trial to be Presented at Society for Vascular Surgery Annual Meeting - Globe Newswire
Mon, Apr 12, 2010
8:31 AM Aastrom Announces Formation of Scientific Advisory Board - Globe Newswire
Wed, Mar 24, 2010
8:32 AM Aastrom Announces Treatment of Final Patient in RESTORE-CLI Clinical Trial - Globe Newswire
Thu, Mar 18, 2010
8:30 AM Aastrom Ticker Symbol Reverts to ASTM - Globe Newswire
More News for ASTM >>

Tags for Aastrom Biosciences Inc.

Research stocks or mutual funds related to Aastrom Biosciences Inc. by keywords or tags. Find companies that have a similar focus to ASTM. The keywords below have been associated to ASTM by either user submission or electronic means.

stem cells information guided tissue regeneration king report on corporate governance history of embryonic stem cell research cloning stem cells human embryonic stem cell stem cell research paper tissue repair neural stem cell stem cell product tissue engineering stem cells china stem cell biology stem cells diabetes embryonic stem cells Biological Products embryo stem cell research save stem cells stem cell tech corporate governance practices stem cell information corporate governance issues define corporate governance board of directors role stem cell news stem cell research debate stem cell research and diabetes investments corporate governance disclosure embryo stem cell board of directors governance directors duties stem cell research articles for stem cell research stem cells therapy Drugs corporate governance hong kong stem cell transplantation stem cell board of directors compensation bone graft dental bone grafting mouse embryonic stem cells embryo stem cells bone substitute stem cell legislation stem cell research legislation stem cell spinal cord injury stem cell research ethics Healthcare

 

NYE - Equity | NYE - ETF | AMX - Equity | AMX - ETF | NSD - Equity | NSD - ETF
NMF - ETF | NMF - Money Market Fund | NMF - Mutual Fund | OTC - Equity | OTO - Equity | OTO - ETF | OTO - Mutual Fund
CNQ - Equity | CBO - Equity | BDM - Equity | TSX - Equity | TSX - ETF | TSX - Mutual Fund | TSV - Equity | TSV - Mutual Fund

Dow Jones Composite Index | Dow Jones Industrial Avg | Dow Jones Transportation Avg | Dow Jones Utiliy Index | NASDAQ 100
Russell 1000 | Russell 2000 | Russell 3000 | Russell Microcap | Russell Midcap | S&P 500 | S&P MidCap 400 | S&P/TSX 60 | S&P/TSX MidCap

Recently Added Symbols   Firms   Find Financial Advisors

Advisors by Name: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

RIAs by Name: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Tags: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Insiders: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

All information displayed and available herein is on an "as is", "as available" basis and neither InvestorPoint.com nor any of its underlying service providers, information providers, licensors, employees, distributors or agents make any representations as to the suitability of our service or the materials for any purpose. The information is not intended for trading purposes or advice. We specifically disclaim any representations or warranties, express or implied, including, without limitation, any representations or warranties of merchantability or fitness for a particular purpose. InvestorPoint.com is not an investment adviser. We do not: (a) give investment advice, (b) advocate the purchase or sale of any security or investment and (c) provide, endorse or review any information or data contained herein. We do not guarantee the accuracy of the information and data supplied by information providers. We are not liable or responsible for the quality, accuracy or reliability of this information. You should always seek the assistance of a professional for investment advice.

Copyright © 2010 InvestorPoint.com All rights reserved.